BXP, Inc. (BXP · NYSE)

BXP shares have fallen 10.4% over the past month to $60.45, leaving the stock 16.3% below its 52-week high with RSI at 31, though the company beat estimates in three of its last four quarters, including Q2 EPS of $1.78 versus $1.71 expected. Fundamentals show pressure: earnings declined 23.2% year over year despite 3.7% revenue growth to $3.19B TTM, and leverage remains elevated at 10.1x debt/EBITDA on $16.36B of total debt, with free cash flow of just $97.3M in the quarter against a $0.70 quarterly dividend. Sequential results improved, with Q2 revenue of $895.7M and EBITDA of $492.9M up from the prior quarter, and the company scheduled Q3 results for October 27. The stock trades at a P/E of 32.5 versus an analyst target of $76.35.